Clinical Trials Logo

Collaboration clinical trials

View clinical trials related to Collaboration.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03203395 Completed - Depression Clinical Trials

Screening for Depression and Anxiety in Patients With Heart Disease

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Depression is a risk factor for morbidity and mortality in patients with heart disease, and has a negative impact on quality of life, work capacity and treatment adherence. Screening for depression among heart patients are therefore recommended by the Norwegian Health Authorities. Also, symptoms of anxiety may negatively affect rehabilitation due to e.g. fear of physical activity and excessive worry. Patients currently receiving treatment for heart disease at Diakonhjemmet Hospital will be screened for symptoms of depression and anxiety. If such symptoms are detected, patients will be offered a counselling session with a clinical psychologist. Further, routines for collaborative communication between clinical psychologist, cardiologist and the patient's general physician will be emphasized.

NCT ID: NCT02628184 Completed - Collaboration Clinical Trials

A Case Study of a Maternity Service Development Programme

Start date: January 2016
Phase:
Study type: Observational

BACKGROUND: In 2011 a Maternity Services Development Programme was implemented in a South of England city, to promote effective collaborative working between maternity services (midwives) and other service providers (health visitors, social workers, specialist services etc.) by co-locating services in local childrens centres. The progamme ultimately aimed to improve care for local service users (women and their families), especially those considered vulnerable. Implemented changes were based on evidence that suggests poor collaborative working contributes to poorer outcomes. RATIONALE: To explore the impact of the programme on local service providers, and by association service user care. AIM: To explore a localised Maternity Services Development Programme, identifying how inter- agency collaborative working occurs, and the service providers perceived benefits and challenges on collaboration, and by association service user care. METHODOLOGY: The proposed research uses a case study approach to collect and analyse predominantly qualitative data, and some quantitative data. Data will be collected using observation episodes (e.g. participant meetings) to observe collaboration, and interviews to explore these experiences. Additionally documents will be analysed to observe documented evidence of collaborative practice. Pre-existing statistical data will also be used to highlight changes in indicators of service user well being since the implementation of the Maternity Services Development Programme. PARTICIPANTS: A cross-section of service providers (no service users) working in or with maternity services from 4 of 9 city Children Centre's. FINDINGS: No current findings, data collection expected to start September 2015.

NCT ID: NCT01403649 Completed - Influenza Clinical Trials

Collaborative Efforts to Increase Flu Vaccination

CollabFlu
Start date: August 2009
Phase: N/A
Study type: Interventional

Beginning with the 2009-2010 season, influenza vaccine is universally recommended for children age 6 months to 18 years old, placing extra burden on health care providers across the U.S. The focus of this study is to develop new strategies and implement existing evidence-based strategies to enhance influenza immunization in these children. The intervention will involve collaboration from different types of primary care providers, the Colorado Immunization Information System (CIIS), public health departments and visiting nursing services (VNA). It will be designed and implemented by those involved with delivery with a focus on sustainability after the completion of the study. Parental input will be gathered during the planning year through focus groups to assist in developing the intervention. Qualitative assessments and examination of processes during the first year of implementation will guide modifications during the second implementation year in order to assure sustainability. Primary outcome measures in the intervention and control groups: 1) increase in the rate of receipt of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children 6 mo.-18 yr. and 2) increase in the rate of children 6 mo.-18 yr. who were fully immunized (received all required influenza injections) during the season. 3) measure outcomes by age group (6 mo.-5 yr., 6-8 yr., 9-12 yr., 13-18 yr.) and types of clinical sites (urban Peds, urban FM, rural FM)